Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS AZ Managed to Speed Up Pilot R&D Projects under New Structure: President
September 25, 2014
-
TRENDS Facing Unprecedented Patent Cliff for Abilify, Otsuka Holdings Sets Forth Plan to Achieve Recovery in 2018
September 24, 2014
-
BUSINESS Mediceo Sets to Increase Qualified Reps to 2,000, Enter Contract PMS Biz within 3 Years
September 22, 2014
-
REGULATORY MHLW Guidelines to Call for Thorough Internal Communications at Pharmas after Novartis’ Delayed ADR Reporting
September 19, 2014
-
BUSINESS MTPC Generic Arm Seeks to Quickly Broaden Product Lineup, New Alliance a Possibility: Pres.
September 18, 2014
-
BUSINESS Nippon Shinyaku to Gear Up R&D, Commercialization of Nucleic Acid Products
September 17, 2014
-
BUSINESS Pharmacy Chains Hurrying to Reach Price Settlements with Wholesalers ahead of Sept.-End Deadline
September 16, 2014
-
BUSINESS Takara Bio Pushes for Melanoma Drug Development with Eye on Fast Approval
September 12, 2014
-
REGULATORY Chuikyo’s Drug Pricing Panel to Continue Discussions on Penalties and Actions against Novartis
September 11, 2014
-
REGULATORY Jichi Medical University President Seen as Prime Candidate for Japan NIH Head
September 10, 2014
-
ACADEMIA Prof. Komuro to Issue Objection to Chiba University in Wake of Second Retraction Request Related to VART Study
September 9, 2014
-
BUSINESS All Eyes Glued to Japan Realignment after Mylan’s Buyout of Abbott’s Established Product Biz
September 8, 2014
-
BUSINESS MSD’s Januvia Logs 1st Sales Decline in Japan on Re-Pricing
September 5, 2014
-
BUSINESS US Court Backs Jury Verdict in Actos Suit, Orders Takeda to Pay US$6 Billion in Punitive Damages
September 5, 2014
-
REGULATORY Industry on Alert as Reformist Shiozaki Tapped as New Health Minister
September 4, 2014
-
REGULATORY Yasuhisa Shiozaki Tapped as New Health Minister
September 3, 2014
-
REGULATORY MOF Official Unami Urges Full-Scale NHI Price Revision upon Next Sales Tax Hike
September 2, 2014
-
BUSINESS Novartis Pharma Submits Improvement Plan, Notifies of Over 2,500 Unreported Serious ADRs
September 1, 2014
-
BUSINESS Sanofi Greater China Head Baschiera to Shepherd Japan Unit
August 29, 2014
-
BUSINESS Roche Obtains First Refusal Right for All Chugai’s Products with Partial Amendment to Strategic Alliance Deal
August 29, 2014
ページ
On March 5, Japan unveiled new NHI prices for the FY2024 drug price revision. A Jiho survey found that Tsumura, a specialist in Japanese Kampo herbal medicines, received an astonishing raise of over 24% in its drug prices on a…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…